MANE (MANE) Stock

Healthcare · Biotechnology · Member of Other US Stocks

MANE (MANE) closed at USD 113.47 on 2026-10-14, a change of +200.6 % over the past year, with a market capitalization of USD 4.81B.

MANE recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MANE key figures

Previous close

USD 113.47 (2026-10-14)

1-year change

+200.6 %

Market cap

USD 4.81B

Enterprise value

USD 3.99B

P/E ratio (trailing)

-27.40

P/E ratio (forward)

-42.71

EPS (trailing)

-4.20

EPS (forward)

-2.69

PEG ratio

n/a

Price to book

5.91

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.78

Employees

37

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MANE

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MANE and compare it with other stocks.